# To Explore the Value of New MR Technology in Non-invasive Quantitative Assessment of Systemic Metabolism, Disease Status and Prognosis in Patients With Metabolic-Associated Fatty Liver Disease

> **NCT07149571** · — · RECRUITING · sponsor: **Tongji Hospital** · enrollment: 500 (estimated)

## Conditions studied

- Nonalcoholic Fatty Liver Disease
- Metabolic-associated Fatty Liver Disease

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07149571
- **Lead sponsor:** Tongji Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-04-01
- **Primary completion:** 2032-12-01
- **Final completion:** 2032-12-31
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2025-09-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07149571

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07149571, "To Explore the Value of New MR Technology in Non-invasive Quantitative Assessment of Systemic Metabolism, Disease Status and Prognosis in Patients With Metabolic-Associated Fatty Liver Disease". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT07149571. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*